Sanjiv Shah, MD
April 11th, 2013
Treatment of Heart Failure with Preserved Ejection Fraction: Why Have All the Clinical Trials Failed, and What Can We Do About It?
Sanjiv Shah, MD and John Ryan, MD
Laying out a road map for better trials and ultimately better outcomes for this confounding condition
November 7th, 2012
Better Evidence, More Comparators Needed in Device Research
Sanjiv Shah, MD
Rita Redberg expands on her research letter in the current JAMA critiquing the lack of good comparative effectiveness data for new, high-risk medical devices.
November 30th, 2011
Thrombolysis Instead of Primary PCI
Sanjiv Shah, MD
The latest analysis of 2009 CMS data for 13,776 STEMI patients of door-in to door-out (DIDO) time by Herrin and colleagues does not bring encouraging news. After many years of hard work to reduce DIDO time for patients who present at facilities without primary PCI capability, only a small fraction of patients (<10%) are transferred […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?